Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Use Of Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope

  • Read more about Use Of Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope
US Application 61/195,845
Filed on 2008-10-10

Use Of Viral Like Particles (VLPs) In The Development Of A Preventive Vaccine Against Chikungunya

  • Read more about Use Of Viral Like Particles (VLPs) In The Development Of A Preventive Vaccine Against Chikungunya
US Application 61/118,206
Filed on 2008-11-26

Flavivirus-Based System for Production of Hepatitis C Virus (HCV)

  • Read more about Flavivirus-Based System for Production of Hepatitis C Virus (HCV)
US Application 61/195,088
Filed on 2008-10-03

Linking Malarial Proteins To OMPC Greatly Increases The Antibody Response To The Protein

  • Read more about Linking Malarial Proteins To OMPC Greatly Increases The Antibody Response To The Protein
US Application 60/681,546
Filed on 2005-05-16

Long-lasting Inhibitors Of Viral Infection

  • Read more about Long-lasting Inhibitors Of Viral Infection
US Application 60/938,403
Filed on 2007-05-16

DNA PRIME/INACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS

  • Read more about DNA PRIME/INACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS
US Application 61/100,621
Filed on 2008-09-26

Leishmania Vaccine Using Sand Fly Salivary Immunogen

  • Read more about Leishmania Vaccine Using Sand Fly Salivary Immunogen
US Application 61/101,345
Filed on 2008-09-30

Use Of Mono-Anine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency

  • Read more about Use Of Mono-Anine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency
US Application 61/111,019
Filed on 2008-11-04

Cell-Based Immunotherapy

  • Read more about Cell-Based Immunotherapy
US Application 61/090,788
Filed on 2008-08-21

Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis

  • Read more about Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis
US Application 61/092,710
Filed on 2008-08-28

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health